Show simple item record

dc.contributor.authorBedia, JS
dc.contributor.authorJacobs, IJ
dc.contributor.authorRyan, A
dc.contributor.authorGentry-Maharaj, A
dc.contributor.authorBurnell, M
dc.contributor.authorManchanda, R
dc.contributor.authorKalsi, JK
dc.contributor.authorDawnay, A
dc.contributor.authorFallowfield, L
dc.contributor.authorMcGuire, A
dc.contributor.authorCampbell, S
dc.contributor.authorParmar, MKB
dc.contributor.authorMenon, U
dc.contributor.authorSkates, SJ
dc.date.accessioned2024-05-30T11:34:21Z
dc.date.available2024-05-30T11:34:21Z
dc.date.issued2024
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/97103
dc.publisherElsevier BVen_US
dc.relation.ispartofThe Lancet
dc.titleEstimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCSen_US
dc.identifier.doi10.2139/ssrn.4834024
pubs.notesNot knownen_US
pubs.publisher-urlhttp://dx.doi.org/10.2139/ssrn.4834024en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record